Does peroxisome Proliferator-Activated Receptor-α Agonism With Fenofibrate Suppress Inflammatory Responses to Evoked Endotoxemia?
These data suggest a lack of systemic antiinflammatory properties of fenofibrate at clinically relevant dosing in humans.
Observers socially exclude patients with pain for which there is no clear medical explanation. These findings have important clinical implications. In particular, social exclusion might have detrimental effects on the mental and physical well-being of patients with pain.